Clinical Trial Update: Embody Post-Market Clinical Follow-Up Study

View source ↗

Summary

This is a post-market follow-up clinical study of Zimmer Biomet's Embody shoulder system, focusing on subscapularis tendon injuries, currently enrolling by invi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subscapularis Tendon Injury

Snippet

Sponsor: Zimmer Biomet | Conditions: Tendon Injuries- Subscapularis | Status: ENROLLING_BY_INVITATION